<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10">
 <label>10</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Festino</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Botti</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Lorigan</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Masucci</surname>
    <given-names>GV</given-names>
   </name>
   <name>
    <surname>Jason Hipp</surname>
    <given-names>JD</given-names>
   </name>
   <name>
    <surname>Horak</surname>
    <given-names>CE</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Cancer Treatment With anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection</article-title>? 
  <source>Drugs</source> (
  <year>2016</year>) 
  <volume>76</volume>:
  <page-range>925–45</page-range>.  
  <pub-id pub-id-type="doi">10.1007/s40265-016-0588-x</pub-id>
 </mixed-citation>
</ref>
